The GenBody is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid and RBD protein antigen from SARS-CoV-2 in direct anterior nasal swab specimens collected from patients within first 6 days of symptom onset. This point-of-care antigen test renders test results in :15 min. For in vitro diagnostic use only.
- Sensitivity: 92.31%
- Specificity: 99.04%
